OncRef watches every approval, readout, pipeline move and congress abstract — and delivers what it means for your asset, pre-cut for Medical Affairs, Clinical Development and Commercial. Updated daily.

Trial changes, publications, approvals, press releases and congress abstracts — more than 400,000 in the past year. OncRef scans them and pulls the relevant insights for you.


Oncology updates go in. Answers for each of your teams come out — already interpreted, no prompting required.


| Study A | Study B | Study C | Study D | |
|---|---|---|---|---|
| Population | ||||
| Biomarker | ||||
| Line of therapy | ||||
| Endpoint | ||||
| Efficacy | ||||
| Safety | ||||
| Comparator |
Exactly what you get from every congress we cover:
Every drug, company, trial and guideline is mapped to a single normalized entity — so a claim in your brief is always one click from its origin. Built for MLR-minded teams.
Traditional intelligence services hand you the haystack. OncRef hands you the needle — and tells you why it matters.

Medical Affairs · Clinical Development · Commercial · BD
Pipeline and landscape research across companies, mechanisms and indications
The interpreted update at the point of care — trials, labels and guidelines for the patients in front of you
“I love this because I can go in and pick my cancer type. Not every app is oncology specific. Especially for oncology centric providers, being able to start at a very specific indication offers more value than other products on the market.”
Monika Buczek, PhDDirector, Taconic Biosciences Strategy, Operations, Product, and Innovation“This is really cool. I've never seen anything like this.”
Patrick Tucker, PhDVP of Medical CommunicationsChoose your team, indications and deliverables — newsletter, custom dashboard or congress coverage. We'll send a sample brief built on your scope. No obligation — or request a demo and we'll set up a call.
